Cigna earnings beat by $0.04, revenue topped estimates
Xylo Technologies Ltd. has filed a request with the district court of Tel Aviv for approval of an arrangement with its shareholders, as disclosed in a recent SEC filing. This move follows shareholder approval obtained at special general meetings held on May 27, 2025. The arrangement, if sanctioned by the court, will result in Xylo Technologies becoming a wholly-owned subsidiary of L.I.A Pure Capital Ltd., which plans to acquire all remaining shares of Xylo Technologies that it does not currently own.
The arrangement is subject to court approval under Section 350 of the Israeli Companies Law. The court’s decision on May 30, 2025, requires objections to be submitted by June 15, 2025. Xylo Technologies has clarified that the completion of this arrangement is contingent upon receiving court approval, and the company cannot guarantee the court’s decision.
Upon successful court approval and completion of the arrangement, Xylo Technologies will delist its American Depositary Shares (ADSs) from the Nasdaq Stock Exchange, effectively ending its obligations as a public company. The company plans to provide further updates on the timeline and closing procedures once additional information becomes available.
This information is based on a statement from Xylo Technologies’ recent SEC filing.
This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.